Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing country
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/content/pdf/10.1007/s12185-014-1627-6.pdf
Reference36 articles.
1. Melo JV, Hughes TP, Apperley JF. Chronic myeloid leukemia. ASH hematology. 2003:132–52.
2. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, et al. Hematologic and cytogenetic responses to Imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346(9):645–52.
3. Sokal JE, Cox EB, Baccarani M, Tuna S, Gomez GA, Robertson JE, et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood. 1984;63(4):789–99.
4. Hasford J, Pfirrmann M, Hehlmann R, et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa: writing committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst. 1998;90(11):850–8.
5. Hasford J, Baccarani M, Hoffmann V, et al. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on Imatinib treatment: the EUTOS score. Blood. 2011;118(3):686–92.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy;Immunogenetics;2022-12-26
2. Meeting the needs of CML patients in resource-poor countries;Hematology;2019-12-06
3. The role of ethnicity in personalized dosing of small molecule tyrosine kinase inhibitors used in oncology;Translational Cancer Research;2017-12
4. Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective;Expert Review of Hematology;2017-08-03
5. Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes;Journal of Global Oncology;2016-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3